OPDP’s Social Science Research Could Impact How You Market Your Drug

In addition to surveillance and enforcement of drug promotion activities, the FDA’s Office of Prescription Drug Promotion (OPDP) also conducts numerous research studies in order to provide better education and guidance to the public. These studies enable the OPDP to

Read More

5 Problems with Your PRC Process and How to Fix Them

We’ve heard it before: You have your shiny new PRC software, but you’re still running into problems that result in inefficient workflows and friction among teams. What’s going on, and what can your team do to improve? Through conversations with

Read More

Government Shutdown Day 33: The Impact on Drug Approvals

As the longest government shutdown in history continues, we at Vodori are wondering how the industry is fairing. Will our customers awaiting FDA approvals see their PDUFA dates slip? How is the FDA monitoring drugs and devices already on the

Read More

That’s a Wrap: Recapping 2018’s Trends, Successes, and Lessons Learned

With 2018 coming to a close, we’re taking some time to reflect on how the industry has evolved this year, what we’ve learned, and how it might influence our future. Over the last year, the FDA issued 7 OPDP letters,

Read More

Setting Your Agency Partners Up for Success

Arming your agencies with key MLR information to avoid common mistakes and get the job done At any one time, you might be working with a dozen or more agency partners who help to create your promotional materials. You’ve shared

Read More

Furthering Vodori’s Commitment to Pre-Launch Success for Life Science Organizations

Why We’re Announcing The Pepper Flow Acceleration Program In the months leading up to a product launch, and in some cases, FDA approval, creation of promotional, medical affairs, disease-state, and market-access materials ramps up exponentially. As the pace and volume

Read More